PRINCETON, New Jersey and OR AKIVA, Israel, November 28, 2017 /PRNewswire/ — Regentis Biomaterials announced today the start of its Phase III pivotal clinical trial of GelrinC for the treatment of focal knee cartilage defects with successful surgery on three patients in the U.S. and Denmark. These procedures are part of a Food and Drug Adminstration […]